ATC Group: D05AX02 Calcipotriol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D05AX02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D05 Antipsoriatics
3 D05A Antipsoriatics for topical use
4 D05AX Other antipsoriatics for topical use
5 D05AX02 Calcipotriol

Active ingredients in D05AX02

Active Ingredient Description
Calcipotriol

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.

Related product monographs

Title Information Source Document Type  
CALCIPOTRIOL Cutaneous solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DAIVONEX Ointment Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
Dovonex Ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.